SurgeCare

Julien Hédou

CEO

jhedou@surge.care

www.surge.care

Who are we ?

Surge is a start-up from Stanford University. Surge’s technology is based on more than ten years of research on surgical risk prediction conducted in Dr. Brice Gaudillière’s laboratory at Stanford University, which was completed by Julien Hédou, who joined his lab in 2018. Surge’s goal is to predict postoperative complications to optimize the management of patients undergoing surgery. The team has developed a test to identify patients at risk of complications. By anticipating the risks associated with surgery and allowing the care pathway to be adapted as closely as possible to the patient’s needs, this innovation promises to revolutionize the standard of care in surgery and the patient experience.

Key Information

–  Medtech

–  Based in Paris, France

– 10 employees

– Created in 2021